Product Code: ETC13369945 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Vaccine Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Vaccine Market - Industry Life Cycle |
3.4 Europe Vaccine Market - Porter's Five Forces |
3.5 Europe Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Europe Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Europe Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Europe Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Europe Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Vaccine Market Trends |
6 Europe Vaccine Market, 2021 - 2031 |
6.1 Europe Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Vaccine Market, Revenues & Volume, By Preventive Vaccines, 2021 - 2031 |
6.1.3 Europe Vaccine Market, Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031 |
6.1.4 Europe Vaccine Market, Revenues & Volume, By DNA Vaccines, 2021 - 2031 |
6.2 Europe Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Vaccine Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.3 Europe Vaccine Market, Revenues & Volume, By COVID19, 2021 - 2031 |
6.2.4 Europe Vaccine Market, Revenues & Volume, By Hepatitis B, 2021 - 2031 |
6.3 Europe Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Vaccine Market, Revenues & Volume, By Pediatrics, 2021 - 2031 |
6.3.3 Europe Vaccine Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.3.4 Europe Vaccine Market, Revenues & Volume, By Geriatrics, 2021 - 2031 |
6.4 Europe Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Vaccine Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.4.3 Europe Vaccine Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.4.4 Europe Vaccine Market, Revenues & Volume, By Oral, 2020 - 2028 |
6.5 Europe Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Vaccine Market, Revenues & Volume, By mRNAbased, 2020 - 2028 |
6.5.3 Europe Vaccine Market, Revenues & Volume, By Viral Vector, 2020 - 2028 |
6.5.4 Europe Vaccine Market, Revenues & Volume, By Protein Subunit, 2020 - 2028 |
7 Europe Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
7.3.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.2 Germany Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.3 France Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.4 Poland Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.5 Spain Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.6 Rest of Europe Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4 Europe Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.2 Germany Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.3 France Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.4 Poland Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.5 Spain Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.6 Rest of Europe Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5 Europe Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Germany Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 France Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 Poland Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.5 Spain Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.6 Rest of Europe Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 Europe Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 United Kingdom (UK) Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Germany Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 France Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.4 Poland Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.5 Spain Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.6 Rest of Europe Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Europe Vaccine Market Key Performance Indicators |
9 Europe Vaccine Market - Export/Import By Countries Assessment |
10 Europe Vaccine Market - Opportunity Assessment |
10.1 Europe Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.4 Europe Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
10.5 Europe Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 Europe Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Europe Vaccine Market - Competitive Landscape |
11.1 Europe Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Europe Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |